Printer Friendly

EMEA alcoholism medicine controls guidelines.

THE EUROPEAN Medicines Agency (EMEA) is to develop detailed guidance on the manufacture, market approval and use of drugs that can treat alcoholism, given that no such formal advice currently exists at a European Union (EU)-level. The guidance will focus on clearly defining target patients, treatment success (whether drugs should end alcoholism, or also reduce drinking), and drug research project organisation. EMEA will also advise whether certain age groups should be excluded from such treatment, as well as patients suffering from other illnesses. Existing treatments include Acamprosate, currently prescribed in the EU for preventing a recurrence of alcoholism, and other medicines are being developed.
COPYRIGHT 2009: A global news agency serving specialist publications with global articles. See
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Nuthall, Keith
Publication:International News
Date:Jan 1, 2005
Previous Article:ECJ Belgium cartel brewery case.
Next Article:Netherlands drinks import tax case ECJ.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |